{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:13:09Z","timestamp":1767093189075,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0108304"],"award-info":[{"award-number":["2018YFA0108304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.imlet.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T01:20:07Z","timestamp":1625361607000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1\/IRF3-regulated-IFN-\u03b3 production"],"prefix":"10.1016","volume":"238","author":[{"given":"Yingyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoliang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengya","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2489-1269","authenticated-orcid":false,"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongquan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.imlet.2021.06.007_bib0001","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.mpaic.2018.08.013","article-title":"Organ donation and management of the potential organ donor","volume":"19","author":"Fleming","year":"2018","journal-title":"Anaesthesia & Intensive Care Medicine"},{"issue":"9","key":"10.1016\/j.imlet.2021.06.007_bib0002","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/tri.12712","article-title":"Optimized donor management and organ preservation before kidney transplantation","volume":"29","author":"Mundt","year":"2016","journal-title":"Transplant International"},{"issue":"5","key":"10.1016\/j.imlet.2021.06.007_bib0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.14740\/jocmr2411w","article-title":"An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation","volume":"8","author":"Khan","year":"2016","journal-title":"Journal of Clinical Medicine Research"},{"key":"10.1016\/j.imlet.2021.06.007_bib0004","unstructured":"A. JK, Cytostatic and immunosuppressant drugs, 2006."},{"issue":"4-5","key":"10.1016\/j.imlet.2021.06.007_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2016.01.006","article-title":"Metabolomics: Perspectives on potential biomarkers in organ transplantation and immunosuppressant toxicity","volume":"49","author":"Bonneau","year":"2016","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.imlet.2021.06.007_bib0006","series-title":"Immunosuppressants","first-page":"271","author":"Dasgupta","year":"2020"},{"issue":"6","key":"10.1016\/j.imlet.2021.06.007_bib0007","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, Inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2021.06.007_bib0008","series-title":"Progress toward islet transplantation tolerance","first-page":"727","author":"Markmann","year":"2020"},{"key":"10.1016\/j.imlet.2021.06.007_bib0009","first-page":"58","article-title":"Strategies to achieve immune tolerance in allogeneic solid organ transplantation","author":"Zeng","year":"2020","journal-title":"Transplant Immunology"},{"issue":"4","key":"10.1016\/j.imlet.2021.06.007_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2016.7","article-title":"Mesenchymal stromal cells in renal transplantation: opportunities and challenges","volume":"12","author":"Casiraghi","year":"2016","journal-title":"Nature Reviews Nephrology"},{"key":"10.1016\/j.imlet.2021.06.007_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00148","article-title":"The Life and Fate of Mesenchymal Stem Cells","volume":"5","author":"Eggenhofer","year":"2014","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.imlet.2021.06.007_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00511","article-title":"Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival","volume":"7","author":"Shen","year":"2016","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/j.imlet.2021.06.007_bib0013","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/eji.201141808","article-title":"Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function","volume":"42","author":"Su","year":"2012","journal-title":"European Journal of Immunology"},{"issue":"4","key":"10.1016\/j.imlet.2021.06.007_bib0014","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.mehy.2007.08.010","article-title":"Mesenchymal stem cells might be used to induce tolerance in heart transplantation","volume":"70","author":"Zhou","year":"2008","journal-title":"Medical Hypotheses"},{"issue":"2","key":"10.1016\/j.imlet.2021.06.007_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tmrv.2011.09.002","article-title":"Bone Marrow\u2013Derived Mesenchymal Stem Cells as Immunosuppressants in Liver Transplantation: A Review of Current Data","volume":"26","author":"Zhang","year":"2012","journal-title":"Transfusion Medicine Reviews"},{"issue":"4","key":"10.1016\/j.imlet.2021.06.007_bib0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/erc.13.5","article-title":"Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration","volume":"11","author":"Zhang","year":"2014","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"9","key":"10.1016\/j.imlet.2021.06.007_bib0017","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.007_bib0018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","article-title":"Donor-Derived Mesenchymal Stem Cells Combined With Low-Dose Tacrolimus Prevent Acute Rejection After Renal Transplantation","volume":"95","author":"Peng","year":"2013","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.imlet.2021.06.007_bib0019","doi-asserted-by":"crossref","first-page":"12089","DOI":"10.18632\/oncotarget.7725","article-title":"Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, nonrandomized study","volume":"7","author":"Guang-hui Pan","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.imlet.2021.06.007_bib0020","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/ajt.15910","article-title":"Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study","volume":"20","author":"Dreyer","year":"2020","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/j.imlet.2021.06.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.16528","article-title":"Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study","author":"Reinders","year":"2021","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"10.1016\/j.imlet.2021.06.007_bib0022","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/tri.12132","article-title":"Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation","volume":"26","author":"Perico","year":"2013","journal-title":"Transplant International"},{"key":"10.1016\/j.imlet.2021.06.007_bib0023","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2017.10.114","article-title":"The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells","volume":"97","author":"Javorkova","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.imlet.2021.06.007_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cytogfr.2019.05.006","article-title":"Mesenchymal stem cells immunomodulation: The road to IFN-\u03b3 licensing and the path ahead","volume":"47","author":"Amandda \u00c9velin Silva- Carvalhoa","year":"2019","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.imlet.2021.06.007_bib0025","first-page":"4","article-title":"Immunomodulatory potential of mesenchymal stem cell role in diseases and therapies: A bioengineering prospective","author":"Taraballi","year":"2019","journal-title":"Journal of Immunology and Regenerative Medicine"},{"issue":"160","key":"10.1016\/j.imlet.2021.06.007_bib0026","doi-asserted-by":"crossref","DOI":"10.3791\/61103","article-title":"Optimization of the Cuff Technique for Murine Heart Transplantation","volume":"26","author":"Ma","year":"2020","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/j.imlet.2021.06.007_bib0027","series-title":"Bancroft's Theory and Practice of Histological Techniques","first-page":"337","article-title":"Immunohistochemical and immunofluorescent techniques","author":"Tracy Sanderson","year":"2019"},{"key":"10.1016\/j.imlet.2021.06.007_bib0028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exer.2012.06.008","article-title":"Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model","volume":"102","author":"Jia","year":"2012","journal-title":"Experimental Eye Research"},{"issue":"2-3","key":"10.1016\/j.imlet.2021.06.007_bib0029","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trim.2011.06.002","article-title":"Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model","volume":"25","author":"Eggenhofer","year":"2011","journal-title":"Transpl Immunol"},{"issue":"8","key":"10.1016\/j.imlet.2021.06.007_bib0030","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1600-6143.2009.02721.x","article-title":"Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance","volume":"9","author":"Ge","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1016\/j.imlet.2021.06.007_bib0031","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.imbio.2019.04.004","article-title":"Interferon regulatory factor 3 plays a role in macrophage responses to interferon-\u03b3","volume":"224","author":"Guinn","year":"2019","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.imlet.2021.06.007_bib0032","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.immuni.2010.11.021","article-title":"Glycogen Synthase Kinase 3\u03b2 Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1","volume":"33","author":"Lei","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2021.06.007_bib0033","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.intimp.2017.06.016","article-title":"Activation of IRF3 contributes to IFN-\u03b3 and ISG54 expression during the immune responses to B16F10 tumor growth","volume":"50","author":"Guinn","year":"2017","journal-title":"International Immunopharmacology"},{"issue":"1-2","key":"10.1016\/j.imlet.2021.06.007_bib0034","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2008.08.004","article-title":"Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate","volume":"20","author":"Popp","year":"2008","journal-title":"Transplant Immunology"},{"issue":"6","key":"10.1016\/j.imlet.2021.06.007_bib0035","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells","volume":"181","author":"Casiraghi","year":"2008","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.007_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2015.7","article-title":"Rap1-mediated nuclear factor-kappaB (NF-\u03baB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction","volume":"1","author":"Zhang","year":"2015","journal-title":"Cell Death Discovery"},{"issue":"10","key":"10.1016\/j.imlet.2021.06.007_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.285","article-title":"Paracrine regulation in mesenchymal stem cells: the role of Rap1","volume":"6","author":"Zhang","year":"2015","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.007_bib0038","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajog.2003.07.022","article-title":"Immunologic properties of human fetal mesenchymal stem cells","volume":"190","author":"G\u00f6therstr\u00f6m","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.007_bib0039","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-017-0742-8","article-title":"Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells","volume":"8","author":"Berglund","year":"2017","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1016\/j.imlet.2021.06.007_bib0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuropharm.2013.11.001","article-title":"Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain","volume":"79","author":"Pischiutta","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.007_bib0041","doi-asserted-by":"crossref","DOI":"10.1186\/s12938-019-0691-9","article-title":"Generation of bioartificial hearts using decellularized scaffolds and mixed cells","volume":"18","author":"Tong","year":"2019","journal-title":"BioMedical Engineering OnLine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:39:13Z","timestamp":1759045153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247821001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":41,"alternative-id":["S0165247821001085"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.06.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1\/IRF3-regulated-IFN-\u03b3 production","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}